| Application | Comment | Organism |
|---|---|---|
| degradation | decreased activity of DLDH induced by valproic acid metabolites may, at least in part, account for the impaired rate of oxygen consumption and ATP synthesis in mitochondria if 2-oxoglutarate or glutamate are used as respiratory substrates, thus limiting the flux of these substrates through the citric acid cycle | Rattus norvegicus |
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| valproyl-CoA | competitive inhibitor, 0.5-1.0 mM inhibit DLDH activity | Rattus norvegicus | |
| valproyl-dephosphoCoA | uncompetitive inhibitor, 0.5-1.0 mM inhibit DLDH activity | Rattus norvegicus |
| Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|
| mitochondrion | - |
Rattus norvegicus | 5739 | - |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Rattus norvegicus | - |
male Wistar rats | - |
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| hepatocyte | - |
Rattus norvegicus | - |
| liver | - |
Rattus norvegicus | - |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| dihydrolipoamide + NAD+ | - |
Rattus norvegicus | lipoamide + NADH | - |
? |
| Synonyms | Comment | Organism |
|---|---|---|
| dihydrolipoamide dehydrogenase | - |
Rattus norvegicus |
| DLDH | - |
Rattus norvegicus |
| E3 | - |
Rattus norvegicus |
| Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
|---|---|---|---|---|---|
| 1.43 | - |
valproyl-CoA | - |
Rattus norvegicus | |
| 1.6 | - |
valproyl-dephosphoCoA | - |
Rattus norvegicus |